Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$501M |
| 2 |
AbbVie
ABBV
|
+$381M |
| 3 |
Eli Lilly
LLY
|
+$377M |
| 4 |
Adobe
ADBE
|
+$368M |
| 5 |
Qualcomm
QCOM
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.38B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.03B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$589M |
| 4 |
Tesla
TSLA
|
+$536M |
| 5 |
Stellantis
STLA
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Healthcare | 15.88% |
| 3 | Consumer Discretionary | 11.4% |
| 4 | Financials | 10.3% |
| 5 | Industrials | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
BioMarin Pharmaceuticals
BMRN
$11.5B
| $113M | 0.06% |
1,167,321
-506,372
| -30% | -$52.5M |
|
327
Alibaba
BABA
$269B
| $113M | 0.06% |
1,142,924
+90,434
| +9% | +$9.06M |
|
328
Clorox
CLX
$11.6B
| $112M | 0.06% |
713,708
+260,080
| +57% | +$39M |
|
329
Organon & Co
OGN
$3.55B
| $112M | 0.06% |
4,726,101
+1,318,768
| +39% | +$35.4M |
|
|
AQUA
330
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $111M | 0.06% |
2,277,404
+54,037
| +2% | +$2.52M |
|
331
Illumina
ILMN
$29.4B
| $111M | 0.06% |
492,786
+1,958
| +0.4% | +$401K |
|
332
Marriott International
MAR
$98.7B
| $111M | 0.06% |
680,129
+183,534
| +37% | +$30.6M |
|
333
Darden Restaurants
DRI
$22.5B
| $110M | 0.06% |
714,652
-765,940
| -52% | -$113M |
|
|
CTRA
334
DELISTED
Coterra Energy
CTRA
| $110M | 0.06% |
4,344,141
+511,348
| +13% | +$12.6M |
|
335
Zimmer Biomet
ZBH
$17.7B
| $110M | 0.06% |
858,163
+52,716
| +7% | +$6.62M |
|
336
Moderna
MRNA
$21.5B
| $110M | 0.06% |
712,810
-94,499
| -12% | -$15.6M |
|
337
Wheaton Precious Metals
WPM
$50.6B
| $109M | 0.06% |
2,200,945
-567,435
| -20% | -$24.8M |
|
338
Corteva
CTVA
$59.7B
| $109M | 0.06% |
1,800,027
-37,298
| -2% | -$2.28M |
|
339
Sun Life Financial
SLF
$45.6B
| $108M | 0.06% |
2,307,817
-291,262
| -11% | -$14M |
|
340
Trade Desk
TTD
$8.13B
| $108M | 0.06% |
1,836,613
+1,106,084
| +151% | +$58.9M |
|
341
Tetra Tech
TTEK
$8.23B
| $107M | 0.06% |
3,717,120
+968,255
| +35% | +$28M |
|
342
Imperial Oil
IMO
$62.1B
| $106M | 0.06% |
1,707,050
+311,706
| +22% | +$15.6M |
|
343
iShares Core S&P 500 ETF
IVV
$876B
| $106M | 0.06% |
258,543
+15,953
| +7% | +$6.4M |
|
344
Vail Resorts
MTN
$5.19B
| $106M | 0.06% |
452,047
+309,097
| +216% | +$74.5M |
|
345
Core & Main
CNM
$8.17B
| $106M | 0.06% |
4,594,243
-81,319
| -2% | -$1.79M |
|
346
NetApp
NTAP
$32.9B
| $105M | 0.06% |
1,655,896
-18,728
| -1% | -$1.21M |
|
|
P
347
Everpure Inc
P
$24.8B
| $105M | 0.06% |
4,139,458
+1,487,084
| +56% | +$40.1M |
|
348
Cintas
CTAS
$82.4B
| $105M | 0.06% |
926,920
+293,492
| +46% | +$32.3M |
|
349
Prudential Financial
PRU
$41.7B
| $105M | 0.06% |
1,263,876
-251,568
| -17% | -$24M |
|
350
Aon
AON
$77.3B
| $105M | 0.06% |
325,286
-93,462
| -22% | -$28.9M |
|
Similar funds
Amundi's Q1 2023 Portfolio in Review
As of Q1 2023, Amundi held 2,154 positions worth $186B, up 1.8% from $182B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Amundi's Q1 2023 filing shows 278 new, 828 increased, 617 reduced and 102 closed positions. Its largest new stake was GE HealthCare: 514,041 shares worth $41.7M. The largest sale was Linde, an estimated $1.38B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q1 2023 buy was GE HealthCare: 514,041 shares worth $41.7M.
- Amundi added most to Intel in Q1 2023, an estimated $501M increase.
- Amundi's biggest Q1 2023 reduction was Linde, cutting an estimated $1.38B.
- Amundi fully exited SVB Financial Group in Q1 2023, selling an estimated $59.9M.
- Amundi's ten largest holdings make up 20% of its $186B portfolio in Q1 2023.
- Amundi opened 278 new positions and closed 102 in Q1 2023.
- Amundi's portfolio value rose 1.8% quarter-over-quarter to $186B.
Based on Amundi's 13F filing for Q1 2023, filed 15 May 2023.